Albumin-Bound Paclitaxel
Showing 4201 - 4225 of 4,750
Surgically-Created Resection Cavity, Drug Safety Trial in Hangzhou (S-1 + Paclitaxel Chemotherapy)
Unknown status
- Surgically-Created Resection Cavity
- Drug Safety
- S-1 + Paclitaxel Chemotherapy
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
Dec 19, 2012
Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in San Antonio (ispinesib,
Completed
- Adenocarcinoma of the Prostate
- +2 more
- ispinesib
- +2 more
-
San Antonio, TexasSouthwest Oncology Group
Jan 24, 2013
Non Small Cell Lung Cancer Trial in Chapel Hill (Paclitaxel, Carboplatin, CPT-11)
Completed
- Non Small Cell Lung Cancer
- Paclitaxel
- +4 more
-
Chapel Hill, North CarolinaUniversity of North Carolina Lineberger Comprehensive Cancer Cen
Feb 1, 2013
Malignant Melanoma Trial in Los Angeles, Miami Beach (Sorafenib (BAY 43-9006), ABI-007(Abraxane))
Completed
- Malignant Melanoma
- Sorafenib (BAY 43-9006)
- ABI-007(Abraxane)
-
Los Angeles, California
- +1 more
May 2, 2012
Stents, Neointimal Proliferation Trial in Jena (Percutaneous coronary intervention with stent implantation)
Completed
- Stents
- Neointimal Proliferation
- Percutaneous coronary intervention with stent implantation
-
Jena, GermanyUniversity Hospital of Jena, 1st Medical Department, Division of
Feb 25, 2013
Critical Limb Ischemia Trial in Arezzo (PEB, POBA)
Completed
- Critical Limb Ischemia
- PEB
- POBA
-
Arezzo, AR, ItalyCardiovascular Department, Ospedale S.Donato
Jan 26, 2013
Peritoneal Cancer Trial in Houston (Bevacizumab, Oxaliplatin, Paclitaxel)
Completed
- Peritoneal Cancer
- Bevacizumab
- +2 more
-
Houston, TexasU.T.M.D. Anderson Cancer Center
Dec 31, 2012
Breast Cancer Trial in Atlanta (Pre operativeTrastuzumab, ABI-007 (Abraxane), Vinorelbine)
Completed
- Breast Cancer
- Pre operativeTrastuzumab
- +2 more
-
Atlanta, Georgia
- +1 more
Jun 16, 2012
Breast Cancer Trial in United States (biological, drug, procedure)
Completed
- Breast Cancer
- filgrastim
- +4 more
-
Mobile, Alabama
- +313 more
Jan 23, 2013
Subarachnoid Hemorrhage Trial in Houston (Human Albumin)
Terminated
- Subarachnoid Hemorrhage
- Human Albumin
-
Houston, TexasBaylor College of Medicine
Dec 10, 2012
Adenosquamous Cell Lung Cancer, Drug/Agent Toxicity by Tissue/Organ, Hemoptysis Trial (biological, drug, radiation)
Completed
- Adenosquamous Cell Lung Cancer
- +5 more
- bevacizumab
- +3 more
-
,California Cancer Consortium
Jan 15, 2013
Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in Birmingham (biological, drug, radiation)
Completed
- Ovarian Cancer
- Primary Peritoneal Cavity Cancer
- recombinant interferon alfa
- +5 more
-
Birmingham, AlabamaUniversity of Alabama Comprehensive Cancer Center
Feb 4, 2013
NSCLC Trial in Worldwide (bexarotene with carboplatin and paclitaxel, carboplatin and paclitaxel)
Completed
- Non-small Cell Lung Cancer
- bexarotene with carboplatin and paclitaxel
- carboplatin and paclitaxel
-
Montgomery, Alabama
- +153 more
Jul 7, 2012
Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma Trial in Phoenix (paclitaxel,
Completed
- Brenner Tumor
- +8 more
- paclitaxel
- +3 more
-
Phoenix, ArizonaGynecologic Oncology Group of Arizona
Jan 23, 2013
Lung Cancer Trial in Chicago, Columbus (biological, drug, procedure)
Completed
- Lung Cancer
- bevacizumab
- +4 more
-
Chicago, Illinois
- +1 more
Feb 8, 2013
Urothelial Cancer, Bladder Cancer Trial in Ann Arbor (Lapatinib and Paclitaxel)
Withdrawn
- Urothelial Cancer
- Bladder Cancer
- Lapatinib and Paclitaxel
-
Ann Arbor, MichiganUniversity of Michigan
Jan 15, 2013
Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer Trial in United States (cisplatin, liposomal doxorubicin,
Non Small Cell Lung Cancer Trial in Beijing (pegylated endostatin and Paclitaxel-Carboplatin, Placebo and
Unknown status
- Non Small Cell Lung Cancer
- pegylated endostatin and Paclitaxel-Carboplatin
- Placebo and Paclitaxel-Carboplatin
-
Beijing, Beijing, ChinaCancer hospital, Chinese academy of medical science
Feb 6, 2012
Stage III-IV or Recurrent Endometrial Cancer Trial in Rome, (Bevacizumab, Carboplatin AUC 5+Paclitaxel 175 mg/mq q 21 for 6-8
Unknown status
- Stage III-IV or Recurrent Endometrial Cancer
- Bevacizumab
- Carboplatin AUC 5+Paclitaxel 175 mg/mq q 21 for 6-8 cycles
-
Rome,, Rome, ItalyCatholic University of Sacred Heart Rome,
Jan 15, 2013
Hypertension Trial in Edinburgh (UVA Radiation)
Completed
- Hypertension
- UVA Radiation
-
Edinburgh, Lothian, United KingdomUniversity of Edinburgh
Feb 19, 2013
Non Small Cell Lung Cancer Trial in Tianjin (M2ES)
Completed
- Non Small Cell Lung Cancer
-
Tianjin, ChinaTianjin Medical University Cancer Institude and Hospital
Jan 28, 2013